This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
Cost-effective, production-ready transmitter solution supports a variety of customer applications including hearing aids, fitness trackers, smartwatches, wireless earbuds and more
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Whitney Tilson recently launched a new investment conference focused on short selling called the Kase Learning Short Selling Conference. They've released some videos of pitches from the presentations and we've aggregated them here along with notes from each talk if you just want a quick summary. Click each link below to go to the presentation. Kase Learning Short Selling Conference Presentations 2018 - Sahm Adrangi (Kerrisdale Capital): On ad fraud and Quinstreet (QNST) - Mark Spiegel (Stanphyl Capital): Short Tesla (TSLA) - Gabriel Grego (Quintessential Capital): Short Folli Follie - Jillian McIntyre (221B Capital): Short Intelsat (I) - Berna Barshay (Viola Capital): Short Ralph Lauren (RL) - Enrique Abeyta: Short Anheuser Busch InBev (BUD) - Chris Brown (Aristides Capital): Short Energous (WATT) - Asher Jacobs & Jade Hu (Columbia MBAs): Short Stericycle (SRCL)
SRCL RL WATT QNST I
EnerSys (ENS - Free Report) delivered fourth-quarter fiscal 2018 adjusted earnings of $1.24 per share, beating the Zacks Consensus Estimate of $1.23. The figure came in at the higher end of the projected range of $1.20-$1.24. The bottom line did not fare as well in a year-over-year comparison, declining 3.1% from the prior-year quarter’s tally of $1.28.
CPST CRSP ENS WATT
Emerson Electric Company (EMR - Free Report) recently announced a new Plantweb Insight application for wireless pressure gauges, with easy usability features. This IIoT (Industrial Internet of Things) application enables maintenance workers to gain a streamlined view of Rosemount wireless pressure gauges, thus enhancing safety.
CPST ENS WATT
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549
watt-10q_20180331.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION
LONDON, UK / ACCESSWIRE / May 9, 2018 / Dialog Semiconductor Plc (XETRA: DLG), a provider of highly integrated power management, AC/DC, solid-state lighting and Bluetooth(R) low energy wireless technology, today reports unaudited results for the first quarter ended 30 March 2018.
Good day and welcome to the Energous Corporation First Quarter 2018 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Please note this event is being recorded.
MS.PRI MS.PRK MS.PRE MS.PRF MS.PRG MS WATT MS.PRA
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
SAN JOSE, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- Energous Corporation (NASDAQ:WATT), the developer of WattUp®, a revolutionary wire-free, over-the-air, power-at-a-distance charging technology, today announced financial results for the first quarter ended March 31, 2018 and provided an update on its operational progress.
Definitive Proxy Statement Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION
One of the hottest names right now is Energous Corp (NASDAQ:WATT), although you wouldn’t know it from a strictly calendar basis. Year-to-date, WATT stock is down nearly 24%, an intractably disastrous start under any other circumstance. But if Energous shares started its run-up a few days later, we would be reading a different story.
AAPL BC94 SMSN WATT SMSD
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to WATT / Energous Corporation on message board site Silicon Investor.
|FWGO Fischer-Watt Gold||McWatters Mining Inc. (MCW on TSE)|
|Wattage Monitor (WMON)||WMON Wattage Monitor|
|Fischer Watt Gold Co.,Inc. - FWGO|
as of ET